Project 2 - Regulation of the T-cell Memory Response in Chlamydia Genital Tract
项目 2 - 衣原体生殖道 T 细胞记忆反应的调节
基本信息
- 批准号:8460760
- 负责人:
- 金额:$ 33.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Adverse effectsAntibodiesBiological MarkersCD4 Positive T LymphocytesCellsCenters of Research ExcellenceCervicalChlamydiaChlamydia InfectionsChlamydia muridarumChlamydia trachomatisChronicDataDevelopmentDiseaseDisease OutcomeEctopic PregnancyEnvironmentEventFemaleFosteringFrequenciesFutureGenerationsGenital systemGoalsHourImmuneImmune responseImmunityImmunizationImmunoglobulin GImmunologic MemoryImmunologicsImmunologyIndividualInfectionInfection preventionInfertilityInflammatory ResponseInterleukin-17InterventionKineticsLaboratoriesLifeLinkMediatingMediator of activation proteinMemoryMentorshipMetricMolecularMusNatural ImmunityOrganismPathogenesisPathologyPelvic Inflammatory DiseasePhenotypePlayPrevalencePrevention strategyPublic HealthPublishingReadingRecruitment ActivityRegimenRegulationReproductionResearchResearch PersonnelResourcesRiskRoleRouteScreening procedureSeriesSexually Transmitted DiseasesSurrogate MarkersT cell responseT memory cellTestingTh1 CellsTherapeuticTissuesTranslatingUnited StatesVaccinationVaccinesadaptive immunitycareerchemokineclinically relevantcytokinegenital infectionhigh riskhuman subjectimprovedin vivointerleukin-23killingsmeetingsmemory CD4 T lymphocytemicrobialmouse modelpreventprogramsreproductiveresearch studyresponseskillstranslational studyvaccine developmentvaccine-induced immunity
项目摘要
Sexually transmitted infections (STI) with Chlamydia trachomatis are the most common bacterial STI in both
the United States and worldwide and represent a significant public health concern. At present, there are no
biomarkers to reliably predict potentially devastating Chlamydia-associated reproductive complications, such
as infertility and ectopic pregnancy; therefore, development of a chlamydial vaccine is a high priority. The
traditional definition of "protective immunity" following chlamydial infection or vaccination includes reduced
bacterial shedding, shortened duration of infection, and diminished chronic tissue damage. However, the
immunologic correlates of protective immunity are less well-defined and have generally included generation
of IgG antibody and a robust CD4+ Th1 response although the latter has also been implicated in pathology
and may not be adequate as a single read-out for immunologic efficacy. The overall goal of this project is to
define the immunologic and cellular responses that contribute to effective generation of Chlamydia
muridarum-specific immunologic memory. We hypothesize that the CD4+ central and effector memory
phenotype elicited following C. muridarum Infection or immunization is a critical determinant of
protective immunity and/or pathology and, as a corollary, that altered IL-23/Th17 responses may result in
inadequate CD4+ T-cell memory responses. Employing a series of in vivo experiments in an established
mouse model, our hypothesis will be tested by the following Specific Aims: 1) Characterize the cellular and
immunologic responses associated with the development of protective CD4+ memory T-cell responses
following Chlamydia muridarum genital tract infection. 2) Evaluate the contribution of the IL-23/Th17
response in generation of effective CD4+ T-cell central and effector memory responses to C. muridarum
genital tract infection. 3) Determine if immunization with killed organisms elicits a different memory response
than natural infection. Information gained from the proposed studies will advance the Project Leader's
immediate and long-term career objectives to expand her technical and analytical research skills, develop
biomarkers for adverse disease outcomes following Chlamydia STI, and translate findings in the basic
immunology laboratory into clinically relevant prevention and intervention strategies for STI. The Project
Leader will integrate enthusiastic mentorship with numerous institutional resources to reach her goal of
becoming an independent investigator with an established scientific niche in genital tract mucosal
immunology.
沙眼衣原体性传播感染是两国最常见的细菌性传播感染
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AMY M. SCURLOCK其他文献
AMY M. SCURLOCK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AMY M. SCURLOCK', 18)}}的其他基金
Immunoregulatory Networks in Chlamydia Genital Tract Infection
衣原体生殖道感染的免疫调节网络
- 批准号:
8196982 - 财政年份:2008
- 资助金额:
$ 33.07万 - 项目类别:
Immunoregulatory Networks in Chlamydia Genital Tract Infection
衣原体生殖道感染的免疫调节网络
- 批准号:
7588300 - 财政年份:2008
- 资助金额:
$ 33.07万 - 项目类别:
Immunoregulatory Networks in Chlamydia Genital Tract Infection
衣原体生殖道感染的免疫调节网络
- 批准号:
7991844 - 财政年份:2008
- 资助金额:
$ 33.07万 - 项目类别:
Immunoregulatory Networks in Chlamydia Genital Tract Infection
衣原体生殖道感染的免疫调节网络
- 批准号:
8389650 - 财政年份:2008
- 资助金额:
$ 33.07万 - 项目类别:
Immunoregulatory Networks in Chlamydia Genital Tract Infection
衣原体生殖道感染的免疫调节网络
- 批准号:
7753218 - 财政年份:2008
- 资助金额:
$ 33.07万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 33.07万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 33.07万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 33.07万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 33.07万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 33.07万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 33.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 33.07万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 33.07万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 33.07万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 33.07万 - 项目类别:














{{item.name}}会员




